secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keenova Therapeutics plc (—)
CIK:        0001567892
Form:       8-K
Filed at:   2025-11-07T23:59:59+00:00
Accession:  0001628280-25-050666
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.03
LLM model:  deepseek-v4-flash:cloud@v2

Mallinckrodt changes fiscal year end to calendar year from late-December fiscal year
--------------------------------------------------------------------------------

- Fiscal year end shifts from last Friday of December to December 31, effective prospectively.
- No transition report required; change adds 5 operating days in FY2025 and 2 in FY2026.
- FY2025 annual report covers Dec 28, 2024 to Dec 31, 2025.
- Quarterly periods in FY2026 will have different operating days, affecting comparability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567892/000162828025050666/0001628280-25-050666-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567892/000162828025050666/mnk-20251107.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-050666

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer